Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Shifting and Focusing Examined in Clinical Sample

J Affect Disord; 2019 Apr 1; Hsu, Forgeard, et al

In contrast to studies conducted in non-clinical samples, attentional focusing appears to be more relevant than attentional shifting in a clinical sample for both depression and anxiety symptoms, according to a recent investigation. These findings, therefore, lend support to efforts to develop neurocognitive interventions that improve focusing. Adults (n=493) presenting for psychiatric treatment completed measures of depressive and anxiety symptom severity and self-reported attentional control. Hierarchical linear regression and Zou's confidence interval method were used to examine the relationship between clinical symptoms and attentional control. Researchers found:

  • Both shifting and focusing were significantly correlated with anxiety and depressive symptoms in this sample.
  • However, focusing was more strongly associated with clinical symptomatology than shifting, which showed a weak correlation.
Citation:

Hsu KJ, Forgeard M, Stein AT, Beard C, Björgvinsson T. Examining differential relationships among self-reported attentional control, depression, and anxiety in a transdiagnostic clinical sample. J Affect Disord. 2019;248:29-33. doi:10.1016/j.jad.2019.01.017.

This Week's Must Reads

Early-Life Stress Linked with Cytomegalovirus in MDD , JAMA Psychiatry; ePub 2019 Mar 6; Ford, et al

Collaborative Intervention for Obesity, Depression , JAMA; 2019 Mar 5; Ma, Goldman Rosas, Lv, et al

Body Weight Predicts Risk for Depressive Symptoms , J Affect Disord; ePub 2019 Mar 5; Vittengl

Slow-Wave Activity and Mood Disturbance in MDD, Psychol Med; 2019 Mar; Goldschmied, et al

Marijuana Use in MDD May Be Contraindicated, Cogn Affect Behav Neurosci; ePub 2019 Feb 26; Radoman, et al

Must Reads in Depression

Early-Life Stress Linked with Cytomegalovirus in MDD , JAMA Psychiatry; ePub 2019 Mar 6; Ford, et al

Collaborative Intervention for Obesity, Depression , JAMA; 2019 Mar 5; Ma, Goldman Rosas, Lv, et al

Body Weight Predicts Risk for Depressive Symptoms , J Affect Disord; ePub 2019 Mar 5; Vittengl

Slow-Wave Activity and Mood Disturbance in MDD, Psychol Med; 2019 Mar; Goldschmied, et al

Marijuana Use in MDD May Be Contraindicated, Cogn Affect Behav Neurosci; ePub 2019 Feb 26; Radoman, et al